HQ, Irvine, CA

Tilda Research Inc.

Urinary Tract Infections

Alopecia Areata

Cartilage Diseases

Eczema

Alzheimer Disease

Atopic Dermatitis

ALZ-801

LY3009104

Baricitinib

PF-04965842

LBP-EC01

Alzheon

Biosolution

Lilly

Locus Biosciences

Pfizer

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

To evaluate the safety and efficacy of implanting pellet-type extracellular matrix-associated autologous chondrocytes (CartiLife®) obtained by cultivating costal chondrocytes of the subject with articular cartilage defects of the knee as a result of trauma or degeneration.

Phase 2 Clinical Trial of CartiLife® in the United States

Tilda Research Inc. | HQ, Irvine, CA

Site insights

Work at this site?

Active trials

Phase 2 Clinical Trial of CartiLife® in the United States

Trial sponsors